Welcome to The Physiology Course

Join us as we explore how to use coronary physiology for the assessment of epicardial coronary artery disease and the coronary microcirculation. The Physiology Course is an in-person experience that includes (1) presentations, debates, and discussions, (2) hands-on training, and (3) live cases.

Our expert faculty will delve into the latest research and advancements in coronary physiology, including wire-based and wireless approaches, providing valuable insights for cardiovascular professionals and researchers alike to improve patient care.

Don't miss the opportunity to join this inaugural coronary physiology course in the United States and deepen your understanding of the vital role that coronary physiology plays in modern PCI and the assessment of patients with coronary microvascular dysfunction.

Save the date for The Physiology Course in Minneapolis, Minnesota on June 5-6, 2025!

Registration opening soon!

Course Directors

Yader Sandoval, MD

Minneapolis Heart Institute, Abbott Northwestern Hospital

Dr. Sandoval is an academic interventional cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital and the Co-Chair for the Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation. He also holds the position of Adjunct Associate Professor of Medicine at the Mayo Clinic College of Medicine and Science.
Emmanouil S. Brilakis, MD, PhD

Minneapolis Heart Institute, Abbott Northwestern Hospital

Dr. Brilakis is the Director of the Center for Complex Coronary Interventions at the Minneapolis Heart Institute and Chairman of the Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation.
Carlos Collet, MD, PhD

Cardiovascular Center OLV Aalst

Dr. Collet is the Co-Director of the Catheterization Laboratory at the esteemed Cardiovascular Center OLV Aalst in Belgium.
Bernard De Bruyne, MD, PhD

Cardiovascular Center OLV Aalst

Dr. De Bruyne is an interventional cardiologist at the Cardiovascular Center OLV Aalst in Belgium. He developed fractional flow reserve (FFR), as well as bolus and continuous thermodilution for assessing the coronary microcirculation. He led the FAME, FAME2, and DEFER randomized trials.